Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z


Division of Vector-Borne Infectious Diseases Dengue: Clinical Manifestations and Epidemiology

 
slide 11 of 17
 Back Menu Table of contents Next
 

Warning Signs for Dengue Shock

Chart: Warning Signs for Dengue Shock

This thermometer illustrates the developments in the illness that are progressive warning signs that DSS may occur.

  • The initial evaluation is made by determining how many days have passed since the onset of symptoms. Most patients who develop DSS do so 3-6 days after onset of symptoms. Therefore, if a patient is seven days into the illness, it is likely that the worst is over.
  • If the fever goes between three and six days after the symptoms began, this is a warning signal that the patient must be closely observed, as shock often occurs at or around the disappearance of fever. Other early warning signs to be alert for include a drop in platelets, an increase in hematocrit, or other signs of plasma leakage.
  • If you document hemoconcentration and thrombocytopenia and other signs of DHF and the patient meets the criteria for DHF, the prognosis and the patient's risk category have changed. Though dengue fever does not often cause fatalities, a greater proportion of DHF cases are fatal.
  • The next concern would be observation of the danger signs—severe abdominal pain, change in mental status, vomiting and abrupt change from fever to hypothermia. These often herald the onset of DSS.
  • The goal of treatment is to prevent shock. The plasma leakage syndrome is self-limited. If you can support the patient through the plasma leakage phase and provide sufficient fluids to prevent shock, the illness will resolve itself.

Esta página en Español

Back | Menu | Next |

CDC Home | Search | Health Topics A-Z |

This page last reviewed February 13, 2002

Division of Vector-Borne Infectious Diseases |
National Center for Infectious Diseases |
Centers for Disease Control and Prevention |
P.O. Box 2087
Fort Collins, Colorado 80522

CDC Privacy Policy | Accessibility |